Filing Details
- Accession Number:
- 0001209191-20-003457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-15 16:08:48
- Reporting Period:
- 2020-01-13
- Accepted Time:
- 2020-01-15 16:08:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-13 | 2,125 | $90.29 | 37,128 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-13 | 300 | $225.27 | 36,828 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-13 | 1,225 | $226.42 | 35,603 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-13 | 300 | $227.56 | 35,303 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-13 | 300 | $228.99 | 35,003 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-13 | 2,125 | $0.00 | 2,125 | $90.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,250 | 2026-07-11 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $225.27 (range $224.75 to $225.57).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $226.42 (range $226.06 to $227.01).
- Open market sales reported on this line occurred at a weighted average price of $227.56 (range $227.53 to $227.62).
- Open market sales reported on this line occurred at a weighted average price of $228.99 (range $228.79 to $229.27).
- The option vests in 16 quarterly installments from 07/12/2016.
Billionaire Hedge Funds
